{"gao_id": "GAO-17-189", "published": "2017-01-31T12:00:00Z", "released": "2017-03-02T07:00:00Z", "summary": "Each year, over 2 million Americans get sick from bacterial infections that are resistant to antibiotics, and at least 23,000 die as a result. There has also been a steady decline in the development of new antibiotics since the 1980s\u2014raising concerns that there may not be enough new antibiotics to replace those that have become ineffective. In response, the FDA has encouraged drug companies to...", "title": "Antibiotics: FDA Has Encouraged Development, but Needs to Clarify the Role of Draft Guidance and Develop Qualified Infectious Disease Product Guidance", "topics": ["Strategic planning", "Requirements definition", "Pharmaceutical industry", "Health Care", "Infectious diseases", "Documentation", "Antibiotics", "Needs assessment", "Substance abuse treatment", "Internal controls", "Federal agencies", "Product evaluation"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-17-189", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-17-189-highlights.pdf"}, {"title": "Full Report (36 pages)", "url": "https://www.gao.gov/assets/gao-17-189.pdf"}, {"title": "Accessible PDF (40 pages)", "url": "https://www.gao.gov/assets/690/682702.pdf"}]}